Results 151 to 160 of about 320,703 (320)
Efficacy of pegylated interferon and ribavirin for retreatment of chronic HCV infection in HIV co-infected patients failing a previous standard interferon-based regimen [PDF]
, 2008 Manuel Crespo, J. A. Mira, Juan A. Pineda, Eva Van den Eynde, Maria José Ríos-Villegas, Antonio Collado, J.A. Girón González, Luís F. López‐Cortés, Mercedes González‐Serrano, Antonio Rivero, Dolores Merino, Rafael Esteban +11 moreopenalex +1 more source[636] THE INFLUENCE OF NUCLEOSIDE FREE HAART ON THE TREATMENT OF CHRONIC HEPATITIS C WITH PEGYLATED INTERFERON/RIBAVIRIN COMBINATION TREATMENT
, 2007 Jürgen K. Rockstroh, G. Ahlenstiehl, M. Vogel, Gerd Klausen, Thomas A. Lutz, Dirk Schuermann, Amina Carlebach, Christoph Mayr, A Carganico, Peter Buggisch, H Klinker, C John, I. Goelz, S Staszewski +13 moreopenalex +1 more sourceSingle-Dose Infliximab in Hepatitis C Genotype 1 Treatmentnaive Patients with High Serum Levels of Tumour Necrosis Factor-Alpha Does Not Influence the Efficacy of Pegylated Interferon Alpha-2B/Ribavirin Therapy [PDF]
, 2014 Curtis Cooper, Stephen D. Shafran, Susan Greenbloom, Robert Enns, John Farley, Nir Hilzenrat, K. Williams, Magdy Elkashab, Nabil Abadir, Manuela G. Neuman +9 moreopenalex +1 more sourcePhase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas
Neuro-Oncology, 2016 R. Jakacki, E. Dombi, S. Steinberg, S. Goldman, M. Kieran, N. Ullrich, I. Pollack, A. Goodwin, P. Manley, J. Fangusaro, Rudy Allen, B. Widemann +11 moresemanticscholar +1 more sourceStatins enhance the efficacy of pegylated interferon-alfa2 in Philadelphia-negative chronic myeloproliferative neoplasms. [PDF]
Blood AdvDavidsen ID, Larsen MK, Löffler L, Skov V, Kjær L, Knudsen TA, Sørensen AL, Christensen SF, Cordua S, Eickhardt-Dalbøge CS, Kristiansen MH, Ellervik C, Wienecke T, Hasselbalch HC. +13 moreeuropepmc +1 more source